EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immune checkpoint inhibitors and endocrinopathies in pediatric brain tumor patients

Carly R Westermann, Tom B Davidson, Kaaren Waters, Ashley S Margol, Clement C Cheung

Journal of Pediatric Endocrinology and Metabolism · 2025

DOI: 10.1515/jpem-2024-0243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2025. Verfasst von Carly R Westermann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Endocrine System Diseases, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Immune checkpoint inhibitors (ICIs) are emerging treatment options for children with brain tumors, who are already at risk for developing endocrinopathies due to tumor location and treatment. Endocrine ICI-related adverse effects (irAEs) are common in adults but poorly characterized in the pediatric population. The aims of this study were to determine in pediatric brain tumor patients in a single institution (1) if endocrine surveillance took place before and after ICIs were initiated, and (2) the occurrence of endocrine irAEs.

Methods

This is a retrospective chart review of 22 pediatric brain tumor patients treated with ICIs at Children’s Hospital Los Angeles between 2010 and 2022. We analyzed endocrine laboratory results, patient demographics, and treatment course.

Results

Most patients (82 %) received surveillance in at least one endocrine system before ICI treatment – all had thyroid function tested (100 %) whereas non-thyroid endocrine functions were seldomly assessed (6–22 %). Only those patients with surveillance prior to treatment had ongoing surveillance after ICI initiation – 100 % for thyroid function and 17–39 % for other endocrine systems. Hypothyroidism was the only endocrine problem diagnosed after ICI initiation, in two patients (9 %). Of note, most patients (68 %) expired during or shortly after ICI treatment.

Conclusions

This is one of the first institutional surveys of pediatric ICIs in a high-volume pediatric brain tumor center. Thyroid surveillance commonly occurred in pediatric patients, revealing diagnoses of hypothyroidism, which is consistent with adult data. However, little information is available for non-thyroid endocrine conditions, reflecting the need for comprehensive and systematic endocrine surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsEndocrine System DiseasesBrain NeoplasmsHumansRetrospective StudiesChildMaleFemaleAdolescentChild, PreschoolFollow-Up StudiesPrognosisInfantYoung Adult

Stichwörter der Autor:innen

brain tumorendocrine diagnosisimmune checkpoint inhibitorsimmune-related adverse eventspediatrics

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA.
  • Cancer and Blood Disease Institute and Division of Hematology and Oncology, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • The Division for Endocrinology, Diabetes, and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Westermann, C. R., Davidson, T. B., Waters, K., Margol, A. S., & Cheung, C. C. (2025). Immune checkpoint inhibitors and endocrinopathies in pediatric brain tumor patients. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2024-0243

Vancouver

Westermann CR, Davidson TB, Waters K, Margol AS, Cheung CC. Immune checkpoint inhibitors and endocrinopathies in pediatric brain tumor patients. Journal of Pediatric Endocrinology and Metabolism. 2025. doi:10.1515/jpem-2024-0243

BibTeX
@article{Westermann2025,
  author = {Westermann, Carly R and Davidson, Tom B and Waters, Kaaren and Margol, Ashley S and Cheung, Clement C},
  title = {Immune checkpoint inhibitors and endocrinopathies in pediatric brain tumor patients},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2025},
  doi = {10.1515/jpem-2024-0243}
}
Kostenlos starten →